Clinical Trial Supply & Logistics for Pharmaceutical Market by Service Type (Packaging & Labeling, Project Management, Storage & Distribution), Phase (Phase I, Phase II, Phase III), Transportation Mode, Temperature Range, Packaging Type, End User

The clinical trial supply and logistics market for pharmaceuticals is entering a pivotal phase, with evolving demands increasing operational complexity and shifting the global competitive landscape. Companies are actively adapting their supply chain strategies to maintain integrity, compliance, and speed amidst tightening regulations and rapid innovation.

Market Snapshot: Clinical Trial Supply & Logistics for Pharmaceutical Market

The Clinical Trial Supply & Logistics for Pharmaceutical Market grew from USD 24.48 billion in 2024 to USD 26.45 billion in 2025. It is expected to continue growing at a CAGR of 7.78%, reaching USD 38.37 billion by 2030. The sector is being shaped by strong investments in digitalization, adaptive logistics, and advanced packaging technologies, as biopharmaceutical leaders pursue more decentralized and patient-centric trial models. Market participants are leveraging collaborative platforms and resilient strategies to navigate new cost and regulatory pressures globally.

Scope & Segmentation

This report delivers detailed coverage and analysis of the clinical trial supply and logistics ecosystem, including:

Service Types: Packaging & labeling, project management, storage & distribution, temperature monitoring, and transportation
Phases: Phase I, Phase II, Phase III, Phase IV
Transportation Modes: Air freight (charter, standard), rail freight (direct, intermodal), road freight (FTL, LTL), sea freight (FCL, LCL)
Temperature Ranges: Ambient, controlled room, frozen, refrigerated
Packaging Types: Active packaging (cryogenic shippers, refrigeration units), hybrid packaging (combined solutions, modular systems), passive packaging (insulated boxes, thermal wraps)
End Users: Biotechnology companies, clinical trial sites, contract research organizations, pharmaceutical companies, third-party logistics providers
Geographic Coverage: Americas (including major US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including leading and emerging countries), Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asian markets)
Featured Technologies: IoT-enabled temperature monitoring, blockchain for shipment tracking, digital twins, reusable packaging systems, predictive analytics
Leading Companies: DHL International GmbH, United Parcel Service, Federal Express Corporation, Thermo Fisher Scientific, Catalent, PCI Pharma Services, World Courier, Marken, Almac Group, Vetter Pharma-Fertigung

Key Takeaways for Senior Decision-Makers

Operational excellence is increasingly driven by real-time data, cross-functional collaboration, and advanced supply chain visibility, enabling faster trial execution and greater adaptability.
Stakeholders are emphasizing sustainability through adoption of reusable packaging, optimized routing, and materials with lower environmental impact, balancing compliance with industry responsibility.
Supply chain resilience is bolstered by diversified supplier networks, regionalized operations, and adaptive risk management processes to address regulatory, geopolitical, and environmental disruptions.
Strategic partnerships and data-sharing frameworks are reducing redundancies, increasing transparency, and harmonizing end-to-end logistics workflows.
Emerging technologies such as IoT and machine learning provide actionable insights for inventory planning, demand forecasting, and immediate issue resolution throughout globally dispersed clinical trial workflows.
Regional variations require customized approaches; in the Americas and Asia-Pacific, infrastructure upgrades and regulatory reforms are especially impactful for trial performance and access.

Tariff Impact

Recent tariff adjustments in the United States have introduced new cost structures in clinical trial supply logistics. Elevated import duties are affecting packaging, specialized components, and auxiliary equipment. This is prompting sponsors and logistics providers to renegotiate supplier contracts, optimize sourcing with nearshore partners, and intensify customs collaboration. Many organizations are implementing tariff classification audits and leveraging free trade agreements to contain costs, while also accelerating digital solutions for customs clearance and shipment visibility.

Methodology & Data Sources

Analysis is based on a hybrid methodology combining primary interviews with senior supply chain stakeholders and secondary research from regulatory literature, peer-reviewed journals, and industry reports. Cross-referenced quantitative data and empirical performance metrics were synthesized and peer-reviewed by sector experts to validate trends and recommendations presented in this study.

Why This Report Matters

Delivers actionable insight for optimizing clinical trial logistics strategies, enhancing operational resilience, and advancing supply chain innovation.
Identifies key market drivers, technology applications, and regional opportunities to support more informed investment and partnership decisions.
Enables benchmarking of organizational readiness for emerging regulatory, tariff, and sustainability expectations in global pharmaceutical supply chains.

Conclusion

The clinical trial supply and logistics market is transforming rapidly, requiring agile, technology-driven responses. Organizations equipped with advanced tools and collaborative networks are positioned to safeguard patient access and accelerate therapeutic innovation.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

5.1. Robust cold chain management solutions for ultra-low temperature mRNA and gene therapy trials
5.2. Implementation of IoT-enabled real-time temperature and humidity monitoring across global trial shipments
5.3. Adoption of AI-driven predictive analytics for proactive risk management in clinical trial logistics
5.4. Sustainable and eco-friendly packaging innovations to reduce carbon footprint in trial supply operations
5.5. Harmonization of international regulatory requirements to streamline cross-border clinical trial distribution
5.6. Deployment of blockchain-based platforms for secure chain of custody and data transparency in trials
5.7. Customized direct-to-patient delivery models optimizing last-mile distribution in decentralized clinical trials

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Service Type

8.1. Introduction
8.2. Packaging & Labeling
8.3. Project Management
8.4. Storage & Distribution
8.5. Temperature Monitoring
8.6. Transportation

9. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase

9.1. Introduction
9.2. Phase I
9.3. Phase II
9.4. Phase III
9.5. Phase IV

10. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Transportation Mode

10.1. Introduction
10.2. Air Freight
10.2.1. Charter
10.2.2. Standard
10.3. Rail Freight
10.3.1. Direct
10.3.2. Intermodal
10.4. Road Freight
10.4.1. Ftl
10.4.2. Ltl
10.5. Sea Freight
10.5.1. Fcl
10.5.2. Lcl

11. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Temperature Range

11.1. Introduction
11.2. Ambient
11.3. Controlled Room
11.4. Frozen
11.5. Refrigerated

12. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Packaging Type

12.1. Introduction
12.2. Active Packaging
12.2.1. Cryogenic Shippers
12.2.2. Refrigeration Units
12.3. Hybrid Packaging
12.3.1. Combined Solutions
12.3.2. Modular Systems
12.4. Passive Packaging
12.4.1. Insulated Boxes
12.4.2. Thermal Wraps

13. Clinical Trial Supply & Logistics for Pharmaceutical Market, by End User

13.1. Introduction
13.2. Biotechnology Companies
13.3. Clinical Trial Sites
13.4. Contract Research Organizations
13.5. Pharmaceutical Companies
13.6. Third-Party Logistics Providers

14. Americas Clinical Trial Supply & Logistics for Pharmaceutical Market

14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina

15. Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market

15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland

16. Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market

16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan

17. Competitive Landscape

17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. DHL International GmbH
17.3.2. United Parcel Service, Inc.
17.3.3. Federal Express Corporation
17.3.4. Thermo Fisher Scientific Inc.
17.3.5. Catalent, Inc.
17.3.6. PCI Pharma Services, LLC
17.3.7. World Courier, LLC
17.3.8. Marken, Inc.
17.3.9. Almac Group Limited
17.3.10. Vetter Pharma-Fertigung GmbH & Co. KG

18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix

List of Figures

FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: RESEARCHAI
FIGURE 28. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: RESEARCHSTATISTICS
FIGURE 29. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: RESEARCHCONTACTS
FIGURE 30. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: RESEARCHARTICLES

List of Tables

TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PROJECT MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PROJECT MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STORAGE & DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STORAGE & DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CHARTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CHARTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STANDARD, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INTERMODAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INTERMODAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FTL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FTL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY LTL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY LTL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FCL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FCL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY LCL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY LCL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AMBIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AMBIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTROLLED ROOM, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTROLLED ROOM, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FROZEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FROZEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CRYOGENIC SHIPPERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CRYOGENIC SHIPPERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATION UNITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATION UNITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COMBINED SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COMBINED SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MODULAR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MODULAR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INSULATED BOXES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INSULATED BOXES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERMAL WRAPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERMAL WRAPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THIRD-PARTY LOGISTICS PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THIRD-PARTY LOGISTICS PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 169. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 171. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 172. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 173. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2024 (USD MILLION)
TABLE 174. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025-2030 (USD MILLION)
TABLE 175. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
TABLE 176. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2025-2030 (USD MILLION)
TABLE 177. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2024 (USD MILLION)
TABLE 178. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2025-2030 (USD MILLION)
TABLE 179. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2024 (USD MILLION)
TABLE 180. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2025-2030 (USD MILLION)
TABLE 181. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
TABLE 182. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2025-2030 (USD MILLION)
TABLE 183. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD MILLION)
TABLE 184. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025-2030 (USD MILLION)
TABLE 185. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 186. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 187. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 188. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 189. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2024 (USD MILLION)
TABLE 190. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2025-2030 (USD MILLION)
TABLE 191. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 192. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 193. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
TABLE 202. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2025-2030 (USD MILLION)
TABLE 203. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2024 (USD MILLION)
TABLE 204. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2025-2030 (USD MILLION)
TABLE 205. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2024 (USD MILLION)
TABLE 206. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2025-2030 (USD MILLION)
TABLE 207. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
TABLE 208. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2025-2030 (USD MILLION)
TABLE 209. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD MILLION)
TABLE 210. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025-2030 (USD MILLION)
TABLE 211. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 214. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 215. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2024 (USD MILLION)
TABLE 216. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2025-2030 (USD MILLION)
TABLE 217. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 218. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 219. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION

Samples

LOADING...

Companies Mentioned

DHL International GmbH
United Parcel Service, Inc.
Federal Express Corporation
Thermo Fisher Scientific Inc.
Catalent, Inc.
PCI Pharma Services, LLC
World Courier, LLC
Marken, Inc.
Almac Group Limited
Vetter Pharma-Fertigung GmbH & Co. KG

Table Information

Report Attribute	Details
No. of Pages	191
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 26.45 Billion
Forecasted Market Value ( USD ) by 2030	$ 38.37 Billion
Compound Annual Growth Rate	7.7%
Regions Covered	Global
No. of Companies Mentioned	10

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3147EUR$3,545USD£2,748GBP €3497EUR$3,939USD£3,053GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3395EUR$3,824USD£2,964GBP €3772EUR$4,249USD£3,293GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4601EUR$5,183USD£4,017GBP €5113EUR$5,759USD£4,463GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5568EUR$6,272USD£4,861GBP €6187EUR$6,969USD£5,401GBP

Clinical Trial Supply & Logistics for Pharmaceutical Market by Service Type (Packaging & Labeling, Project Management, Storage & Distribution), Phase (Phase I, Phase II, Phase III), Transportation Mode, Temperature Range, Packaging Type, End User - Global Forecast 2025-2030

Market Snapshot: Clinical Trial Supply & Logistics for Pharmaceutical Market